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SUMMARY
We report the case of a 65-year-old man presenting
with generalised seizures after developing a right frontal
brain abscess. Stereotactic aspiration and subsequent
matrix assisted laser desorption/ionisation time-of-ﬂight
analyzer (MALDI-TOF) spectrometry revealed
Porphyromonas gingivalis as the only causative anaerobe
microorganism. Secondary incision and drainage was
required due to neurological deterioration with increased
dimensions of the abscess, intracranial pressure and
formation of a subdural occipitoparietal empyema. Oral
imaging was positive for apical periodontitis of multiple
elements; therefore, the remaining dentition was
removed. Targeted antibiotic treatment included
intravenous ceftriaxone and ornidazole. The patient was
discharged to our revalidation unit 59 days after
admission to make a full recovery. To the best of our
knowledge, this is the sixth reported case of P. gingivalis
causing an intracranial abscess and the third case of a
true intracerebral parenchymal abscess caused by this
bacterium.
BACKGROUND
Brain abscesses of odontogenic origin are rarely
seen and account for only a small fraction of all
reported cerebral abscesses. The incidence of cere-
bral abscesses ranges from 0.4 to 0.9 cases per
100 000 people and is more frequent in im-
munocompromised patients. Oral pathogens cause
3–10% of abscesses,1 while other causative patho-
gens are non-oral bacteria, mycobacteria, fungi or
parasites. The underlying pathogenic mechanisms are
poorly understood. Contiguous spread of a pathogen is
the most frequent route of infection. Haematogenous
or lymphatic dissemination is seen in a limited
number of cases.2 The initial presentation, symp-
toms and results from clinical and radiological inves-
tigations vary widely and are non-speciﬁc for the
causative pathogen.3–4 Morbidity and mortality
have improved in recent years due to better imaging
techniques and therapeutic options. Mortality
ranges from 0 to 24% for odontogenic brain
abscesses.5 Porphyromonas gingivalis, a gram-
negative oral pathogen, has rarely been reported in
subjects with cerebral abscess formation, but has
been widely associated with periodontitis. Its patho-
genesis is still being investigated, but includes a wide
variety of immunological escape mechanisms.
We searched databases (Medline, Scopus, Web of
Science, EMBASE, Cochrane library) and manually
searched reference lists for relevant articles and
related cases. Well-accepted reviews served as the
foundation for this article. Additional original arti-
cles were selected by reading the abstract and
obtaining the full text when needed. Search terms
included: brain abscess, cerebral abscess, P. gingiva-
lis, odontogenic, periodontitis, parodontitis, tooth
infection and oral pathogen. Five articles were
selected that discussed intracranial abscess forma-
tion by P. gingivalis.
CASE PRESENTATION
We report the case of a 65-year-old man with a
medical history of prostate carcinoma, for which he
underwent radical prostatectomy with adjuvant
radiotherapy. The patient also had type 2 diabetes,
hypertension, hypercholesterolaemia and epilepsy
of unknown origin during his childhood. Home
medications included acetylsalicylic acid, olmesar-
tan medoxomil, rosuvastatin, lixisenatide, metfor-
min and gliclazide. The patient was previously
treated with valproate, which was reduced and then
stopped 6 months earlier as the patient was seizure
free for over 20 years. Previous imaging reports
never mentioned intracranial anomalies. Detailed
ﬁndings and events are illustrated in the patient’s
timeline (ﬁgure 1).
In August 2016, he was admitted after a general-
ised epileptic seizure at home. The patient’s wife
reported that he was increasingly confused in the
preceding days. The clinical neurological examin-
ation was normal with a Glasgow Coma scale
(GCS) of 15/15. Blood tests were unremarkable
except for a slightly increased C reactive protein
(CRP) of 5.9 mg/L (reference <5.0 mg/L). An EEG
was normal. A CT scan of the skull was performed
showing a hypodense, contrast-enhanced lesion sur-
rounded by oedema in the right frontal lobe (ﬁgure
2, video 1). No midline shift or ventricular anomal-
ies were noted. An initial oncologic screening was
advised with imaging of the chest and abdomen
due to the medical history, but did not show
primary malignancies or recurrence. After neuro-
surgical counsel, MRI with diffusion-weighted
imaging (DWI) was added to the diagnostic
workup and a brain abscess with pachymeningitis
was diagnosed (ﬁgure 3, video 2). In light of these
ﬁndings, a transthoracic ultrasound was negative
for cardiac vegetations or signs of infection. Initial
treatment consisted of systemic valproate (1.5 g/
day), levetiracetam (1 g/day), vancomycin (2 g/day),
ornidazole (1 g/day) and ceftriaxone (2 g/day).
Stereotactic drainage was performed and
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Figure 1 Timeline of patient showing
important clinical events, imaging and
intervention dates, and antibiotic and
antiepileptic treatments. T°,
temperature; CRP, C reactive protein.
Figure 2 Initial contrast-enhanced CT imaging at the day of
admission showing a hypodense nodular lesion in the right frontal lobe
with peripheral ring-like contrast uptake as well as perilesional
oedema. The conclusion was possible malignancy, preferably
metastasis.
Video 1 Initial contrast-enhanced CT imaging at the day of admission
showing a hypodense nodular lesion in the right frontal lobe with
peripheral ring-like contrast uptake as well as perilesional oedema. The
conclusion was possible malignancy, preferably metastasis.
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MALDI-TOF spectrometry of the pus (Bruker Daltonik Maldi
Biotyper) revealed P. gingivalis as the sole causative bacterium
(score 2.231, high-conﬁdence identiﬁcation). Intraoral inspec-
tion showed partial dentition complicated with parodontitis. On
previous CT imaging, apical periodontitis was seen around the
elements 16, 23 and 34 (ﬁgure 4), and the sinus cavities
appeared normal. The antibiotic regimen was reduced to intra-
venous ornidazole (1 g/day) and ceftriaxone (2 g/day).
Nineteen days after initial drainage, left hemiparesis and left
hemineglect developed as well as an increase in epileptic sei-
zures with one tonic–clonic seizure. The patient further
deteriorated with need for intubation and intravenous sedation.
Imaging showed the intracerebral abscess was extending to the
subdural space and subcutis, forming a subdural empyema and
spreading to the occipital–parietal regions; therefore, incision
and drainage (ﬁgure 5) was necessary. Owing to clinical instabil-
ity, total extraction of the remaining dentition was performed in
a separate procedure. Antibiotic treatment included intravenous
ceftriaxone (2 g/day) and ornidazole (1 g/day), which were con-
tinued for a total of 43 days until clinical, biochemical and
radiological improvement. The patient was discharged from the
neurosurgical ward after 59 days with almost complete reso-
lution of the neurological deﬁcit. He was referred for inhospital
physiotherapy to regain full motor function.
DISCUSSION
To the best of our knowledge, this is the sixth reported case of
intracranial abscess formation by P. gingivalis and the third case
of a true intracerebral parenchymal abscess.6–10 An overview of
reported cases is given in table 1. It is well known that the oral
cavity hosts a wide variety of microbiological organisms. Studies
identiﬁed up to 350 different bacterial strains in marginal peri-
odontitis and up to 150 strains in endodontic infection.5 Some
of these oral commensals cause opportunistic infections, for
example, streptococcal endocarditis after dental procedures has
been the rationale for endocarditis prophylaxis in high-risk
cardiac patients. Iatrogenic or covert bacteremia arising from the
oral cavity rarely causes clinical pathology requiring interven-
tion. It is extremely rare for P. gingivalis to cause an intracranial
abscess and it has only been reported ﬁve times in current litera-
ture (table 1). This highly adapted non-motile gram-negative
oral anaerobe is strongly associated with periodontitis and can
be cultured in 85.7% of patients diagnosed with periodontitis
compared with 23.1% of healthy subjects.11 Being an opportun-
istic pathogen, it has high virulence as indicated by bioﬁlm
formation, dipeptidyl peptidase intravenous activity, strong
Figure 3 MRI with T1 (left) and
diffusion-weighted imaging (right)
showing central diffusion restriction
suggestive of a cerebral abscess. The
dural layer is thickened, indicating
pachymeningitis.
Video 2 MRI with diffusion-weighted imaging showing central
diffusion restriction, suggestive of a cerebral abscess. The dural layer is
thickened, indicating pachymeningitis.
Figure 4 Periodontal apical
radiolucent areas of elements 16 (left),
23 (middle) and 34 (right).
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induction of proinﬂammatory cytokine secretion and the inva-
sion potential of epithelial cells to escape immune response acti-
vation.12 Other reported extraoral infections, other than
intracranial, caused by P. gingivalis include otitis media, appen-
dicitis, gas gangrene, thoracic empyema and lung abscess
formation.13
An analysis of the cases (table 1) indicated most subjects
present over the age of 50; however, one case of subdural
empyema was reported in a 34-year-old man. In all previous
case reports, no underlying immunodeﬁciency was reported.
Our patient suffered from type 2 diabetes mellitus, an auto-
immune inﬂammatory condition known to disrupt the blood–
brain barrier leading to leakage of small arterioles, possibly
facilitating haematogenous dissemination.14 Presenting symp-
toms were non-speciﬁc for the causative organism and depended
on the location and elevated intracranial pressure. Suspicion
should be raised when an oral or dental pathology is present.
Comorbidities must be taken into account. A full blood count
with inﬂammatory markers, electrolytes, kidney and liver func-
tion tests, blood glucose levels and blood cultures are advised.
Cranial contrast-enhanced CT imaging is the preferred initial
radiologic investigation followed by MRI with DWI. This
case demonstrates the additional beneﬁt of MRI-DWI in
Figure 5 CT imaging 12 days after initial abscess drainage.
Subcutaneous collection (arrow) with gas locules (arrowhead), new
manifestation of the subdural occipitoparietal empyema (small arrow)
and increased cerebral oedema.
Table 1 Reported cases of intracranial abscesses caused by Porphyromonas gingivalis
Reference Sex
Age
(years)
Predisposing
factors Pathogen Oral pathology
Presenting
symptoms Localisation Treatment Outcome
8 F 64 Eisenmenger’s
syndrome,
ventricular
septal defect
Lactobacillus
catenaformis
P. gingivalis
Fusobacterium
nucleatum
Periodontitis 15 Seizures Right temporal
lobe
Initial AB: Ceftriaxone,
metronidazole, vancomycin
Switched AB (D2):
sulbactam/ampicillin
Surgical: drainage (D2),
craniotomy (D26)
Discharge
after 27 days,
referred to
other hospital
6 F 57 ? P. gingivalis
detected in
CSF
Single tooth
infection, not
further specified
Fever Headache
Gait disturbance
Site not specified.
Additional
ventriculitis
Initial AB: fosfomycin,
panipenem, cephalothin
(intraspinal)
Switched AB (D10):
piperacillin, cefozopran,
cephalothin (ventricular
injection)
Surgical: tooth extraction
Discharge
after 21 days.
Full recovery
10 M 67 None reported P. gingivalis None reported Throbbing
right-sided
headache
Right cavernous
sinus
Infraorbital cavity
Sphenoid sinus
Initial AB: carbapenem
Switched AB (D15):
ampicillin, sulbactam
Surgical: drainage,
endoscopic sphenoidotomy
Full recovery
7 M 54 None reported P. gingivalis Periodontitis Right-sided
homonymous
hemianopsia
Right
hemiparesis
Left
parieto-occipital
lobe
Initial AB: vancomycin, 3rd
generation cephalosporin,
metronidazole
Switched AB (D10):
ampicillin, sulbactam
Switched AB (D14):
amoxicillin, clavulanate
Surgical (D0): craniotomy
Full recovery
9 M 34 None reported P. gingivalis Sinusitis
(bilateral
frontal,
ethmoid, and
left maxillary)
Fever
Headache
Photophobia
Left hemiparesis
Repeated
vomiting
Right frontal
subdural
empyema
Initial AB: ceftriaxone,
metronidazole
Surgical: frontoparietal
craniectomy (D2),
ethmoidectomy (D2),
bilateral anterior
ethmoidectomy (D2),
bilateral frontal sinectomy
(D2), second drainage (D15)
Full recovery
AB, antibiotic treatment; CSF, cerebrospinal fluid; D, day; F, female; M, male.
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differentiating benign abscesses from primary or metastatic
malignancies; moreover, MRI-DWI can screen for ventriculitis.
If present, hydrocephalus can develop with the need for ven-
tricular drainage. After a diagnosis is made, possible sites of
origin should be further clinically or radiologically investigated.
Transthoracic ultrasound to visualise possible endocarditis or
valvulitis with bacterial vegetations and oral inspection is of
paramount importance to treat underlying infective sources.
Treatment should always include neurosurgical expertise to
assess the feasibility of diagnostic and therapeutic stereotactic
aspiration. Empiric antibiotic treatment should begin as soon as
a brain abscess is suspected. Usually a third-generation broad
spectrum antibiotic such as cephalosporin, metronidazole and
vancomycin is administered intravenously until positive culture
growth or identiﬁcation through mass spectrometry directs the
antibiotic treatment. In most previously reported cases, this
approach was followed (4/5). Treatment duration varies but is
usually 4–6 weeks. The need for additional interventions should
be based on clinical, laboratory and radiological ﬁndings.
Drainage was performed in all reported cases. Tooth extraction
was only reported in one previous case. The mortality and mor-
bidity rates after intracranial P. gingivalis abscess formation are
hopeful. All patients (6/6) made a full recovery; however,
reported mortality rates vary from 0 to 24% in cerebral
abscesses due to odontogenic infection.5 Small sample size does
not allow to draw statistically signiﬁcant conclusions however,
we caution not to minimize the possible pathological severity of
this organism.
Learning points
▸ Porphyromonas gingivalis is a rare but potentially
life-threatening anaerobe that can cause intracerebral
abscesses.
▸ CT imaging cannot always diagnose a cerebral abscess; thus,
MRI with diffusion-weighted imaging should be added to
the diagnostic workup.
▸ Quick initiation of broad-spectrum antibiotics, preferably
after taking cultures, is paramount.
▸ Neurosurgical intervention and timing depends on clinical,
laboratory and radiological ﬁndings but can be useful
diagnostically to elucidate the causative pathogen.
▸ The source of infection should be investigated and treated
accordingly.
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